Submitted:
08 October 2024
Posted:
09 October 2024
You are already at the latest version
Abstract
Background: Urinary tract infections (UTI) are a significant health concern, particularly in women, with almost half of them experiencing at least one UTI in their lifetime. This problem is further compounded by the high recurrence rate within 6-12 months. Postmenopausal women are especially vulnerable to recurrent UTI due to the natural decline in estrogen levels, which alters the urogenital epithelium and subsequently affects the urogenital microbiome. Methods: This study included 674 female patients that were admited at "Dr. Carol Davila" Central Military Emergency University Hospital in Bucharest over a period of 3 years. Results: Of the 674 women with urinary tract infection, 435 (79.3%) had more than one positive culture, and 239 (35.4%) experienced at least one recurrent urinary tract infection 6-12 months after the initial diagnosis. The mean age of women with urinary tract infection was 63 (± 15.61 years). Recurrent urinary tract infections were most prevalent in those aged 65-80 years (52%). Escherichia coli was detected in 71% of the positive cultures. Conclusions: The management of recurrent urinary tract infections in women presents a complex challenge that necessitates a multifaceted approach. The emerging understanding of the urobiome and its role in bladder health offers promising avenues for developing targeted interventions. As research in this field advances, it is imperative to integrate these new insights into clinical practice to balance traditional antibiotic treatments with novel strategies that consider the intricate microbial ecosystem of the urinary tract.
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Setting
2.3. Study Population
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Cortes-Penfield NW, Trautner BW & Jump RLP Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults. Infect. Dis. Clin. North Am 31, 673–688 (2017). [CrossRef]
- Wu Y. (Rose) et al. Recurrent Urinary Tract Infections Due to Bacterial Persistence or Reinfection in Women—Does This Factor Impact Upper Tract Imaging Findings? J. Urol 196, 422–428 (2016). [CrossRef]
- Al-Mukhtar Othman J, Åkervall S, Milsom I & Gyhagen M Urinary incontinence in nulliparous women aged 25–64 years: a national survey. Am. J. Obstet. Gynecol 216, 149.e1–149.e11 (2017). [CrossRef]
- Pearce MM et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio 5, e01283–14 (2014). [CrossRef]
- Abrams P et al. The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction. Neurourol. Urodyn 36, 2109–2116 (2017). [CrossRef]
- Pietropaolo A, Jones P, Moors M, Birch B & Somani BK Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review. Curr. Urol. Rep 19, 78 (2018). [CrossRef]
- Vihta KD, Stoesser N, Llewelyn MJ et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records. Lancet Infect Dis 2018; 18: 1138–49. [CrossRef]
- Klein RD, Hultgren SJ. Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nat Rev Microbiol 2020; 18: 211–26. [CrossRef]
- Malmartel A, Ghasarossian C. Epidemiology of urinary tract infections, bacterial species and resistances in primary care in France. Eur J Clin Microbiol Infect Dis 2016; 35: 447–51. [CrossRef]
- NICE, Urinary tract infection (lower)—women: How should I assess a person with suspected UTI? 2023. https://cks.nice.org.uk/topics/urinary-tract-infection-lower-women/diagnosis/assessment/.
- Izett-Kay M, Barker KL, McNiven A et al. Experiences of urinary tract infection: a systematic review and meta-ethnography. Neurourol Urodyn 2022; 41: 724–39. [CrossRef]
- Glover M, Moreira G, Sperandio V et al. Recurrent urinary tract infections in healthy and nonpregnant women. Urol Sci 2014; 25: 1–8. [CrossRef]
- Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28: 1–13. [CrossRef]
- Khasriya R et al. Lower urinary tract symptoms that predict microscopic pyuria. Int. Urogynecol. J 29, 1019–1028 (2018). [CrossRef]
- Ennis SS, Guo H, Raman L, Tambyah PA, Chen SL, Tiong HY. Premenopausal women with recurrent urinary tract infections have lower quality of life. Int J Urol. 2018 Jul;25(7):684–689. [CrossRef]
- Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, Schubert S, Wagenlehner F, Mezei T, Pilatz A, Pradere B, Veeratterapillary R. EAU guidelines on urological infections. EAU Guidelines Office, European Association of Urology (EAU): Arnhem, The Netherlands; 2020.
- Cai T. Recurrent uncomplicated urinary tract infections: definitions and risk factors. In: Bjerklund Johansen TE, Wagenlehner FME, Matsumoto T, Cho YH, Krieger JN, Shoskes D, Naber KG, editors. Urogenital Infections and Inflammations. Düsseldorf: GMS; 2017.
- Cai T, Mazzoli S, Migno S, Malossini G, Lanzafame P, Mereu L, Tateo S, Wagenlehner FM, Pickard RS, Bartoletti R. Development and validation of a nomogram predicting recurrence risk in women with symptomatic urinary tract infection. Int J Urol. 2014 Sep;21(9):929–934. [CrossRef]
- Flower A, Bishop FL, Lewith G. How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC Fam Pract. 2014 Sep;15:162. [CrossRef]
- Renard J, Ballarini S, Mascarenhas T, Zahran M, Quimper E, Choucair J, Iselin CE. Recurrent Lower Urinary Tract Infections Have a Detrimental Effect on Patient Quality of Life: a Prospective, Observational Study. Infect Dis Ther. 2014 Dec;4(1):125–135. [CrossRef]
- Brubaker L & Wolfe AJ The new world of the urinary microbiota in women. Am. J. Obstet. Gynecol. 213, 644–649 (2015). [CrossRef]
- Juthani-Mehta M et al. Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes. JAMA 316, 1879 (2016). [CrossRef]
- Wu Y. (Rose) et al. Recurrent Urinary Tract Infections Due to Bacterial Persistence or Reinfection in Women—Does This Factor Impact Upper Tract Imaging Findings? J. Urol 196, 422–428 (2016). [CrossRef]
- Jung C et al. The Microbiota of Women with Recurrent Urinary Tract Infection: Opportunities to Improve Clinical Care. In: The 43rd Annual Meeting of the International Urogynecological Association; 2018 Jun 27–30; Vienna, Austria Abstract Num 37.
- Al-Mukhtar Othman J, Åkervall S, Milsom I & Gyhagen M Urinary incontinence in nulliparous women aged 25–64 years: a national survey. Am. J. Obstet. Gynecol 216, 149.e1–149.e11 (2017).
- Hooton TM, Roberts PL, Cox ME & Stapleton AE Voided midstream urine culture and acute cystitis in premenopausal women. N. Engl. J. Med 369, 1883–91 (2013). [CrossRef]
- Pietropaolo A, Jones P, Moors M, Birch B & Somani BK Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review. Curr. Urol. Rep 19, 78 (2018). [CrossRef]
- Hessdoerfer E, Jundt K & Peschers U Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int. Urogynecol. J 22, 229–232 (2011). [CrossRef]
- Huang B, Fettweis JM, Brooks JP, Jefferson KK & Buck GA The changing landscape of the vaginal microbiome. Clin. Lab. Med. 34, 747–61 (2014). [CrossRef]
| Parameter | Total UTI n(%) N= 674 |
Single UTI n(%) N= 435 | Recurrent UTI n(%) N= 239 |
P -value |
|---|---|---|---|---|
| Age | 63 ± 15.61 | 57.5 ± 16.46 | 73.3 ± 17.43 | < 0.002 |
| 20-30 | 90 (13.3) | 61(14.1) | 29 (12.1) | < 0.003 |
| 31-40 | 125 (18.5) | 107 (24.6) | 18 (7.5) | < 0.001 |
| 41-50 | 103 (15.2) | 72 (16.5) | 31(12.9) | < 0.003 |
| 51-60 | 186 (27.5) | 105 (24.1) | 81 (33.9) | < 0.002 |
| ≥ 65 | 130 (19.2) | 52 (12) | 78 (32.6) | < 0.002 |
| BMI (Mean ± SD) | 30.3 ± 4.3 | 28.1 ± 5.2 | 29.6 ± 4.9 | 0.341 |
| Comorbidities | ||||
| Chronic renal disease | 174 (25.9) | 43 (9.8) | 131 (54.8) | < 0.001 |
| Hypertension | 387 (57.4) | 241 (55.4) | 146 (61.1) | 0.002 |
| Malignancies | 87 (12.9) | 23 (5.2) | 64 (26.7) | 0.102 |
| Heart failure | 205 (30.4) | 109 (25.1) | 96 (40.1) | 0.82 |
| Stroke | 214 (31.7) | 121 (27.8) | 93 (38.9) | 0.210 |
| Diabetes | 291 (43.1) | 112 (25.7) | 179 (74.9) | < 0.002 |
| Risk factors | ||||
| Recent urinary catheter | 318 (47.1) | 117 (26.8) | 201 (84.1) | < 0.002 |
| Neurogenic bladder | 23 (3.4) | 2 (0.4) | 21 (8.7) | < 0.003 |
| Polycystic kidney disease | 2 (0.2) | 1 (0.2) | 1 (0.4) | 0.106 |
| Urological and gynecological procedures | 31 (4.6) | 3 (0.6) | 28 (11.7) | < 0.001 |
| Immobilization | 92 (13.6) | 7 (1.6) | 85 (35.5) | < 0.002 |
| Incomplete bladder emptying | 10 (1.4) | 1 (0.2) | 9 (3.7) | |
| Etiologic agent | ||||
| Escherichia coli | 271 (40.2) | 127 (29.1) | 144 (60.2) | 0.86 |
| Klebsiella pneumonia | 106 (15.7) | 49 (11.2) | 57 (23.8) | 0.91 |
| Enterococcus faecalis | 77 (11.4) | 41 (9.4) | 36 (15.1) | <0.001 |
| Pseudomonas aeruginosa | 52 (7.7) | 34 (7.8) | 18 (7.5) | <0.002 |
| Streptococcus agalactiae | 47 (6.9) | 36 (8.2) | 11 (4.6) | <0.002 |
| Staphilococcus aureus | 62 (9.1) | 42 (9.6) | 20 (8.3) | <0.001 |
| Candida auris | 59 (8.7) | 28 (6.4) | 31 (13.1) | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).